Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +23.33%
#4 Solv Protocol xSolvBTC Solv Protocol xSolvBTC +22.84%
#5 Victoria VR Victoria VR +21.15%
#6 Nockchain Nockchain +18.95%
#7 Bedrock Bedrock +17.00%
#8 Versatize Coin Versatize Coin +12.50%
#9 Perle Perle +12.25%
#10 Velvet Velvet +12.00%
Coin of the day
EXOD EXOD
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Peringkat dalam Saham #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Harga Saham
$0.00060315
Terakhir disinkronkan: 2024-09-27
Kapitalisasi Pasar
$1.65M
Perubahan (1 hari)
19.64%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Amniotics AB (publ) (AMNI)

Kategori

Healthcare
Laba untuk Amniotics AB (publ) (AMNI)
Laba pada Dec 2023 TTM: $-3.09M
Menurut laporan keuangan terbaru dari Amniotics AB (publ), laba saat ini perusahaan adalah $-3.09M. Pada tahun 2022, perusahaan memperoleh laba sebesar $-4.61M, peningkatan dibandingkan laba tahun 2021 sebesar $-5.92M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Amniotics AB (publ) dari 2018 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
2026 (TTM) $-3.09M 0.85%
2023 $-3.06M -33.59%
2022 $-4.61M -22.23%
2021 $-5.92M 57.96%
2020 $-3.75M 235.76%
2019 $-1.12M 45.50%
2018 $-767.77K 0.00%
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -171,033.57%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -63,310.98%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -97,500.51%
BE